Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 5 studies | 29% ± 12% | |
| smooth muscle cell | 3 studies | 30% ± 11% |
Insufficient scRNA-seq data for expression of AVPR1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 97% | 2669.35 | 444 / 459 | 89% | 3.86 | 999 / 1118 |
| thymus | 99% | 1879.52 | 649 / 653 | 71% | 4.43 | 431 / 605 |
| adrenal gland | 100% | 8072.23 | 257 / 258 | 50% | 6.16 | 114 / 230 |
| uterus | 97% | 2131.11 | 165 / 170 | 46% | 2.29 | 211 / 459 |
| liver | 91% | 3029.38 | 206 / 226 | 51% | 9.55 | 207 / 406 |
| prostate | 66% | 457.43 | 161 / 245 | 71% | 2.09 | 357 / 502 |
| kidney | 69% | 614.85 | 61 / 89 | 64% | 11.70 | 581 / 901 |
| bladder | 81% | 684.57 | 17 / 21 | 46% | 1.78 | 234 / 504 |
| esophagus | 46% | 342.75 | 662 / 1445 | 72% | 2.05 | 131 / 183 |
| adipose | 100% | 4081.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| skin | 43% | 310.32 | 771 / 1809 | 53% | 2.53 | 252 / 472 |
| stomach | 42% | 340.37 | 152 / 359 | 53% | 1.70 | 153 / 286 |
| pancreas | 5% | 25.34 | 18 / 328 | 81% | 5.30 | 145 / 178 |
| intestine | 48% | 360.96 | 460 / 966 | 35% | 0.97 | 182 / 527 |
| ovary | 21% | 285.88 | 37 / 180 | 60% | 1.63 | 259 / 430 |
| blood vessel | 74% | 4438.92 | 993 / 1335 | 0% | 0 | 0 / 0 |
| lung | 10% | 55.42 | 55 / 578 | 46% | 1.73 | 527 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 1.10 | 21 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 0.50 | 8 / 29 |
| muscle | 27% | 168.09 | 220 / 803 | 0% | 0 | 0 / 0 |
| heart | 24% | 142.73 | 206 / 861 | 0% | 0 | 0 / 0 |
| brain | 0% | 2.01 | 10 / 2642 | 23% | 0.55 | 164 / 705 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.11 | 4 / 80 |
| spleen | 2% | 22.29 | 6 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.41 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007625 | Biological process | grooming behavior |
| GO_0006091 | Biological process | generation of precursor metabolites and energy |
| GO_0014049 | Biological process | positive regulation of glutamate secretion |
| GO_0019722 | Biological process | calcium-mediated signaling |
| GO_0032849 | Biological process | positive regulation of cellular pH reduction |
| GO_0030307 | Biological process | positive regulation of cell growth |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_0014902 | Biological process | myotube differentiation |
| GO_0045907 | Biological process | positive regulation of vasoconstriction |
| GO_0032870 | Biological process | cellular response to hormone stimulus |
| GO_0031394 | Biological process | positive regulation of prostaglandin biosynthetic process |
| GO_0042713 | Biological process | sperm ejaculation |
| GO_0051970 | Biological process | negative regulation of transmission of nerve impulse |
| GO_0001992 | Biological process | regulation of systemic arterial blood pressure by vasopressin |
| GO_0002125 | Biological process | maternal aggressive behavior |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0042711 | Biological process | maternal behavior |
| GO_0003084 | Biological process | positive regulation of systemic arterial blood pressure |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0007621 | Biological process | negative regulation of female receptivity |
| GO_0008015 | Biological process | blood circulation |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0035176 | Biological process | social behavior |
| GO_0042631 | Biological process | cellular response to water deprivation |
| GO_0051412 | Biological process | response to corticosterone |
| GO_0010460 | Biological process | positive regulation of heart rate |
| GO_0021537 | Biological process | telencephalon development |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0005768 | Cellular component | endosome |
| GO_0005080 | Molecular function | protein kinase C binding |
| GO_0042277 | Molecular function | peptide binding |
| GO_0017046 | Molecular function | peptide hormone binding |
| GO_0031894 | Molecular function | V1A vasopressin receptor binding |
| GO_0005000 | Molecular function | vasopressin receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | AVPR1A |
| Protein name | Vasopressin V1a receptor Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor) |
| Synonyms | AVPR1 |
| Description | FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. Has been involved in social behaviors, including affiliation and attachment. . FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. . FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. . FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. . |
| Accessions | ENST00000550940.1 P37288 F8VW98 X5D2B0 X5D789 ENST00000299178.4 |